Has the 6-Min Walk Distance Run Its Course?

Slides:

Advertisements

Similar presentations

Volume 32, Issue 1, Pages (July 1957)

Advertisements

Thoracic Endometriosis

Volume 32, Issue 1, Pages (July 1957)

Volume 34, Issue 2, Pages (August 1958)

Tell-tale Telangiectasias

Volume 104, Issue 2, Pages (August 1993)

Colloquium on Therapy of Right Heart Failure

Silvestri Gerard A. , MD, FCCP, Rivera M. Patricia , MD, FCCP CHEST

An Unusual Cause of Stridor and Progressive Shortness of Breath

When to Be Rash About a Fever and Headache

Right-Sided Chest Pain with Progressive Dyspnea

Volume 102, Issue 3, Pages (September 1992)

Epidemiology and Treatment of Lung Cancer in Seattle

Volume 133, Issue 4, Pages (April 2008)

Efficacy of Inhalational Nitric Oxide Therapy in the Clinical Management of Persistent Pulmonary Hypertension of the Newborn John P. Kinsella, M.D.,

Hyperbaric Oxygenation in Cardiac and Pulmonary Disease

Varicosities of the Pulmonary Veins

Volume 121, Issue 2, Pages (February 2002)

Air Pollution and Chest Disease

Navin K. Jain, MD, Thiam H. Lie, MD, FCCP CHEST

The Effects of Helium-Hyperoxia on 6-min Walking Distance in COPD

Volume 96, Issue 6, Pages (December 1989)

Oxygen Therapy Titrated to Raise Mixed Venous Oxygen Content in COPD

Advance Directive Education During Pulmonary Rehabilitation

Effects of Long-term Infusion of Prostacyclin on Exercise Performance in Patients With Primary Pulmonary Hypertension Wax David , MD, Garofano Robert.

Volume 133, Issue 5, Pages (May 2008)

Stenting To Reverse Left Ventricular Ischemia Due To Left Main Coronary Artery Compression in Primary Pulmonary Hypertension Stuart Rich, MD, FCCP, Vallerie.

Frank W. Ewald, MD, FCCP, Albert H. Scherff, MD CHEST

The Lung Cancer Stage Page

Treatment of Small Cell Lung Cancer

Acute Pulmonary Exacerbations of Sarcoidosis

Krishman. Padmanabhan, M.D., F.C.C.P., Santi R. Dhar, M.D., F.C.C.P

Counterpoint: Adherence to Early Goal-Directed Therapy

Airway Stenting for Patients With Benign Airway Disease and the Food and Drug Administration Advisory Lund Mark E. , MD, FCCP, Force Seth , MD, FCCP

Bronchospasm Secondary to Replacement Estrogen Therapy

Decortication after 35 Years

Sleep Apnea, Hypothyroidism and Pulmonary Edema

Volume 152, Issue 4, Pages (October 2017)

Coin Lesions of the Lung Due to Dirofilaria Immitis

Point: Adherence to Early Goal-Directed Therapy

Reversal of the Anticoagulant Effects of Warfarin by Vitamin K1

Imaging for the Management of Community-Acquired Pneumonia

Prognosis of Pulmonary Arterial Hypertension*

Horn Evelyn M. , MD, Barst Robyn J. , MD, Poon Michael , MD CHEST

Point: Should We Abandon FEV1/FVC <0

Spread the Word About CHEST in 2015

Possible Role of Statins in COPD-Related Pulmonary Hypertension

Brahms' Lullaby Revisited

Augusto Miyashiro, M.D., Soul J. Grosberg, M.D., Simon Wapnick, M.D.

Therapy for Pulmonary Arterial Hypertension in Adults

Bedside Calibration Of Pulmonary Artery Catheters

Invasive Pulmonary Aspergillosis

Pulmonary Manifestations in a Case of Multiple Myeloma

Volume 149, Issue 4, Pages e103-e105 (April 2016)

A Single Nasal Prong for Continuous Oxygen Therapy

Myocardial Sarcoidosis Unresponsive to Steroids

Interaction of Rifampin and Glyburide

Volume 42, Issue 2, Pages (August 1962)

Calcification of the Coronary Artery

Thoracic Surgery Survey on Lung Cancer Management

Digitalis and Angina Pectoris

Volume 133, Issue 4, Pages (April 2008)

Systemic Inflammation, COPD, and Pulmonary Hypertension

Use of Endobronchial Ultrasound for Bedside Diagnosis of Acute Pulmonary Embolism in a Critically Ill Patient Colleen L. Channick, MD, FCCP, Richard.

Pulmonary Artery Rupture Illustrations

Hyperventilation Syndrome

Richard G. Masson, M.D., F.C.C.P., Luke G. Tedeschi, M.D. CHEST

New Members of the Editorial Board

Rebuttal From Dr Kollef

Chronic Pseudomonas aeruginosa Pneumonia in a Normal Adult

Presentation transcript:

Has the 6-Min Walk Distance Run Its Course? Vallerie V. McLaughlin, MD, FCCP CHEST Volume 142, Issue 6, Pages 1363-1365 (December 2012) DOI: 10.1378/chest.12-1110 Copyright © 2012 The American College of Chest Physicians Terms and Conditions

Figure 1 Given the changes in PAH treatment, short-term assessment of 6MWD may not be the best PAH trial end point in 2012. 6MWD =6-min walk distance; EU = European Union; FC = functional class; PAH = pulmonary arterial hypertension; Pts = patients; Tx = therapy; US = United States. CHEST 2012 142, 1363-1365DOI: (10.1378/chest.12-1110) Copyright © 2012 The American College of Chest Physicians Terms and Conditions